Why timestamp drift between wearable sensors quietly undermines decentralized trial data, and why almost no one is asking about it.
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why Legacy RTSM Systems Create Risk in Biosimilar Trials
Learn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.
-
From Data Delays To Decision Speed
The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.
-
Designing Technology for Real-World Research
From workflow design to smarter notifications, practical site-focused solutions can reduce complexity, improve efficiency, and better support clinical research teams.
-
Why Amendments Break Trials and How Elosity R3 Fixes It
Protocol amendments are inevitable. The challenge is managing them without disrupting trial execution.
-
Supply Without Drag: Why Modern Supply Execution Needs a Different Kind of RTSM
Gain visibility, flexible supply management, and real-time decision support to reduce waste, control costs, and align supply with evolving trial needs.
-
Reducing Supply Risk in Cell & Gene Therapy Trials
In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.
-
Configuration Over Code: Why RTSM Architecture Matters Long After Go-Live
Learn how configuration-driven RTSM architecture can simplify protocol changes, reduce operational burden, and help teams manage amendments with greater efficiency and control.
-
The FDA's Remote Regulatory Assessments: The Future Of Inspections
Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.
-
The Case For A Unified eClinical Platform In Clinical Trials
Coordinating and centralizing eClinical platform functionality is essential to enabling agility and flexibility in the modern clinical trial landscape.
-
OpenClinica EDC: Friendly & Easy to Deploy?
Find out how OpenClinica stands out in the global EDC landscape through its user-friendly interface, strong integration capabilities, and extensive partnerships.
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- Designing eCOA Technology Patients Can Actually Use
RECENT NEWSLETTERS
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch